Pulmonary aspergillosis masquerading as progressive post-transplant lymphoma

Transplant International

Volumn 9, Issue 5, 1996, Pages 517-519

  Kirn, David ^a,b   Venook, Alan ^b   Penn, Israel ^c  

^a ONYX PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Aspergillosis, lymphoma; Lymphoma, aspergillosis

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FUNGUS CULTURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG ASPERGILLOSIS; LUNG BIOPSY; LYMPHOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL;

EID: 0029760210     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb00999.x     Document Type: Article

References (13)

1. Cleary ML, Warnke R, Sklar J (1984) Monoclonality of lymphoproliferative lesions in cardiac transplant recipients. N Engl J Med 310: 477
2. Cockfield SM, Preiksaitis J, Harvey E, Parfrey NA (1991) Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc 23: 1106
3. Cockfield SM, Preiksaitis JK, Jewell LD Parfrey NA (1993) Posttransplant lymphoproliferative disorder in renal allograft recipients. Transplantation 56: 88
4. Dodd GO, Ledesma-Medina J, Baron RL, Fuhrman CR (1992) Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 184: 65
5. Dummer JS, Hardy A, Poorsattar A, Ho M (1983) Early infections in kidney, heart and liver transplant recipients on cyclosporine. Transplantation 36: 259
6. Hanto DW, Birkenbach M, Frizzera G, Gajl-Peczalska KJ, Simmons RL, Schubach WH (1989) Confirmation of the heterogeneity of post-transplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 47: 458
7. Nalesnik MA, Locker J, Jaffe R (1992) Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transpl 6: 249
8. Patton DF, Wilkowski CW, Hanson CA, Shapiro R, Gajl-Peczalska KJ, Filipovich AH, Schubach WH (1990) Epstein-Barr virus-determined clonality in post-transplant lymphoproliferative disease. Transplantation 49: 1080
9. Paya CV (1993) Fungal infections in solid organ transplantation. Clin Infect Dis 16: 677
10. Penn I (1989) Why do immunosuppressed patients develop cancer? In: Pimentel E (ed) CRC Critical reviews in oncogenesis. CRC, Boca Raton, pp 1, 27
11. Penn I (1992) Irnmunosuppression - a contributory factor in lymphoma formation. Clin Transpl 6: 214
12. Penn I (1994) Malignancy. Surg Clin North Am 74: 1247
13. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet I: 583